© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Galmed Pharmaceuticals Ltd. is owned by the company. MORGAN STANLEY owns 204.25K shares valued at $87.11K, which translates its holding of 12.16% of the stake in the company.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GLMD shares is N/A, representing N/A of the company's common stock.
, in the last quarter, reduced its stake in GLMD by -100% restricting it's holding to 0 shares of worth nearly -. BVF INC/IL also lessened -22.53% of the GLMD shares from its portfolio, reducing its holding to 1.35 million shares of worth $574.82K. JANE STREET GROUP, LLC also shunned GLMD shares holding by -51.55% last quarter which brought its holding to 13.19 thousand shares worth $5.63K.
As per its latest 13F filing, MORGAN STANLEY increased its stake in GLMD by 13.01% in the last quarter. The institutional holder raised its holding to 204.25 thousand shares having worth more than $87.11K. BNP PARIBAS ARBITRAGE, SNC also added 2,186% more shares of GLMD to its portfolio, raising its holding to 13.72 thousand shares of worth $5.85K. NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO also increased its GLMD shares holding by 100% which brought its holding to 10 shares worth $4.00.
The insider with the most stakes in GLMD is N/A , N/A at the company. Additionally, GLMD stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own N/A percent of Galmed Pharmaceuticals Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which GLMD insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 0 transaction(s) during the past 6-months in which Galmed Pharmaceuticals Ltd. insiders have bought stock, totalling 0 shares
Around 0 Galmed Pharmaceuticals Ltd. shares are held by insiders, which represents about N/A of GLMD stock.
GLMD N/A, N/A holds the largest portfolio of the company's shares. GLMD shares owned by N/A total nearly -.
is the largest institutional owner in GLMD which holds 0 shares worth - or 0% of the total GLMD shares outstanding followed by MORGAN STANLEY with ownership of 204.25 thousand shares representing 12.16% of the GLMD ownership. RAYMOND JAMES & ASSOCIATES is the third largest stakeholder with 138.04 thousand shares or 8.22% of the ownership worth more than $58.87K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GLMD is concerned, it is a stock which is not optionable.
Number of GLMD shares short is 45.88K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 1.66M shares of GLMD are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GLMD has 523.08K shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GLMD is 0.27.